Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes
Fu‐Shun Yen, Ming‐Chih Hou, James Cheng‐Chung Wei, Ying‐Hsiu Shih, Chung Y. Hsu, Chih‐Cheng Hsu, Chii‐Min Hwu
Topics & Concepts
MedicineCirrhosisAgonistGlucagon-like peptide 1 receptorGlucagon-like peptide-1Type 2 diabetesExenatideInternal medicineEndocrinologyGlucagonDiabetes mellitusReceptorGastroenterologyInsulinLiver Disease and TransplantationDiabetes Treatment and ManagementLiver Disease Diagnosis and Treatment